title: No evidence of increased oxidative degradation of urate to allantoin in the CSF and serum of patients with multiple sclerosis.
authors.forename: Stefan
authors.initials: S
authors.lastname: Kastenbauer
authors.forename: Bernd C
authors.initials: BC
authors.lastname: Kieseier
authors.forename: Bernhard F
authors.initials: BF
authors.lastname: Becker
mesh_terms: D000328:Adult; D000481:Allantoin / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000097:blood* / Q000134:cerebrospinal fluid*; D018384:Oxidative Stress / Q000502:physiology*; D014527:Uric Acid / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*
chemical_list: D014527:Uric Acid; D000481:Allantoin
references.citation: J Neurol. 2001 Feb;248(2):121-6
references.pmid: 11284129
references.citation: Neurol Sci. 2002 Oct;23(4):183-8
references.pmid: 12536287
references.citation: Mult Scler. 2001 Jun;7(3):165-6
references.pmid: 11475439
references.citation: Eur J Neurol. 2002 May;9(3):221-6
references.pmid: 11985629
references.citation: Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):675-80
references.pmid: 9435251
references.citation: J Neurol. 1999 Jul;246(7):533-9
references.pmid: 10463352
references.citation: Neurology. 2002 Jan 22;58(2):186-91
references.pmid: 11805243
references.citation: J Neurol. 2004 Mar;251(3):261-8
references.pmid: 15015004